Total Asset Turnover
since 2005
Calculation
Illumina Inc., total asset turnover, long-term trends, calculation
| Total asset turnover | = | Revenue1 | ÷ | Total assets1 | |
|---|---|---|---|---|---|
| Dec 31, 2020 | 0.43 | = | 3,239) | ÷ | 7,585) |
| Dec 29, 2019 | 0.48 | = | 3,543) | ÷ | 7,316) |
| Dec 30, 2018 | 0.48 | = | 3,333) | ÷ | 6,959) |
| Dec 31, 2017 | 0.52 | = | 2,752) | ÷ | 5,257) |
| Jan 1, 2017 | 0.56 | = | 2,398) | ÷ | 4,281) |
| Jan 3, 2016 | 0.60 | = | 2,220) | ÷ | 3,688) |
| Dec 28, 2014 | 0.56 | = | 1,861) | ÷ | 3,340) |
| Dec 29, 2013 | 0.47 | = | 1,421) | ÷ | 3,019) |
| Dec 30, 2012 | 0.45 | = | 1,149) | ÷ | 2,566) |
| Jan 1, 2012 | 0.48 | = | 1,056) | ÷ | 2,196) |
| Jan 2, 2011 | 0.49 | = | 903) | ÷ | 1,839) |
| Jan 3, 2010 | 0.47 | = | 666) | ÷ | 1,430) |
| Dec 28, 2008 | 0.42 | = | 573) | ÷ | 1,377) |
| Dec 30, 2007 | 0.37 | = | 367) | ÷ | 988) |
| Dec 31, 2006 | 0.61 | = | 185) | ÷ | 301) |
| Jan 1, 2006 | 0.73 | = | 74) | ÷ | 101) |
Based on: 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-29), 10-K (reporting date: 2018-12-30), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2017-01-01), 10-K (reporting date: 2016-01-03), 10-K (reporting date: 2014-12-28), 10-K (reporting date: 2013-12-29), 10-K (reporting date: 2012-12-30), 10-K (reporting date: 2012-01-01), 10-K (reporting date: 2011-01-02), 10-K (reporting date: 2010-01-03), 10-K (reporting date: 2008-12-28), 10-K (reporting date: 2007-12-30), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2006-01-01).
1 US$ in millions
The financial data reveals several notable trends over the examined period. Revenue has shown a general upward trajectory from 74 million US dollars in early 2006, reaching a peak of 3,543 million US dollars by the end of 2019. Following this peak, there is a slight decline observed in 2020, with revenue decreasing to 3,239 million US dollars.
Total assets have increased substantially throughout the period, beginning at 101 million US dollars in 2006 and rising consistently to 7,585 million US dollars by the end of 2020. This steady growth indicates significant expansion in asset base.
Total asset turnover, which measures the efficiency in using assets to generate revenue, displays variability. Initially, the ratio was relatively high at 0.73 in early 2006 but declined sharply to a low of 0.37 by the end of 2007. Thereafter, the ratio recovers somewhat, fluctuating between 0.42 and 0.60 over the years. However, from 2018 onwards, a downward trend resumes, ending at 0.43 in 2020.
- Revenue
- There is a strong growth trend from 2006 to 2019, with revenue increasing approximately 48 times over this span. The decline in 2020 may indicate market or operational challenges encountered during that year.
- Total Assets
- Total assets increased more than 75 times over 15 years, reflecting ongoing investment and asset accumulation. This growth likely supports expanding operations and capacity.
- Total Asset Turnover
- The initial decrease followed by partial recovery and subsequent decline suggests fluctuating efficiency in asset utilization. Despite asset growth and rising revenue, turnover ratios have not sustained higher levels, implying growing assets may not be fully optimized to generate proportionate revenue increases, especially toward the latter years.
Overall, the data reflects rapid growth in both revenue and asset base, accompanied by challenges in maintaining consistently high asset turnover ratios. The slight revenue decline in the most recent year combined with a decreasing asset turnover ratio could warrant further analysis to assess operational efficiency and market conditions impacting performance.
Comparison to Competitors
Illumina Inc., total asset turnover, long-term trends, comparison to competitors
| Illumina Inc. | AbbVie Inc. | Amgen Inc. | Bristol-Myers Squibb Co. | Danaher Corp. | Eli Lilly & Co. | Gilead Sciences Inc. | Johnson & Johnson | Merck & Co. Inc. | Pfizer Inc. | Regeneron Pharmaceuticals Inc. | Thermo Fisher Scientific Inc. | Vertex Pharmaceuticals Inc. | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dec 31, 2020 | 0.43 | 0.30 | 0.39 | 0.36 | 0.29 | 0.53 | 0.36 | 0.47 | 0.52 | 0.28 | 0.50 | 0.47 | 0.53 |
| Dec 29, 2019 | 0.48 | 0.37 | 0.37 | 0.20 | 0.29 | 0.57 | 0.36 | 0.52 | 0.55 | 0.31 | 0.53 | 0.44 | 0.50 |
| Dec 30, 2018 | 0.48 | 0.55 | 0.34 | 0.64 | 0.42 | 0.56 | 0.34 | 0.53 | 0.51 | 0.34 | 0.57 | 0.43 | 0.49 |
| Dec 31, 2017 | 0.52 | 0.40 | 0.27 | 0.62 | 0.39 | 0.51 | 0.37 | 0.49 | 0.46 | 0.31 | 0.67 | 0.37 | 0.70 |
| Jan 1, 2017 | 0.56 | 0.39 | 0.28 | 0.58 | 0.37 | 0.55 | 0.53 | 0.51 | 0.42 | 0.31 | 0.70 | 0.40 | 0.59 |
| Jan 3, 2016 | 0.60 | 0.43 | 0.29 | 0.52 | 0.43 | 0.56 | 0.62 | 0.53 | 0.39 | 0.29 | 0.73 | 0.41 | 0.41 |
| Dec 28, 2014 | 0.56 | 0.72 | 0.28 | 0.47 | 0.54 | 0.53 | 0.71 | 0.57 | 0.43 | 0.29 | 0.73 | 0.39 | 0.25 |
| Dec 29, 2013 | 0.47 | 0.64 | 0.28 | 0.42 | 0.55 | 0.66 | 0.48 | 0.54 | 0.42 | 0.30 | 0.71 | 0.41 | 0.52 |
| Dec 30, 2012 | 0.45 | 0.68 | 0.31 | 0.49 | 0.55 | 0.66 | 0.44 | 0.55 | 0.45 | 0.32 | 0.66 | 0.46 | 0.55 |
| Jan 1, 2012 | 0.48 | — | 0.31 | 0.64 | 0.54 | 0.72 | 0.47 | 0.57 | 0.46 | 0.36 | 0.34 | 0.44 | 0.64 |
| Jan 2, 2011 | 0.49 | — | 0.34 | 0.63 | 0.59 | 0.74 | 0.64 | 0.60 | 0.43 | 0.35 | 0.42 | 0.51 | 0.08 |
| Jan 3, 2010 | 0.47 | — | 0.36 | 0.61 | 0.57 | 0.80 | 0.67 | 0.65 | 0.24 | 0.23 | 0.51 | 0.47 | 0.05 |
| Dec 28, 2008 | 0.42 | — | 0.40 | 0.70 | 0.73 | 0.70 | 0.72 | 0.75 | 0.51 | 0.43 | 0.36 | 0.50 | 0.18 |
| Dec 30, 2007 | 0.37 | — | 0.41 | 0.74 | 0.63 | 0.70 | 0.64 | 0.75 | 0.50 | 0.42 | 0.13 | 0.46 | 0.33 |
| Dec 31, 2006 | 0.61 | — | 0.41 | 0.70 | 0.75 | 0.71 | 0.63 | 0.76 | 0.51 | 0.42 | 0.11 | 0.18 | 0.23 |
| Jan 1, 2006 | 0.73 | — | 0.41 | 0.68 | 0.87 | 0.60 | 0.48 | 0.87 | 0.49 | 0.44 | 0.16 | 0.62 | 0.29 |
Based on: 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-29), 10-K (reporting date: 2018-12-30), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2017-01-01), 10-K (reporting date: 2016-01-03), 10-K (reporting date: 2014-12-28), 10-K (reporting date: 2013-12-29), 10-K (reporting date: 2012-12-30), 10-K (reporting date: 2012-01-01), 10-K (reporting date: 2011-01-02), 10-K (reporting date: 2010-01-03), 10-K (reporting date: 2008-12-28), 10-K (reporting date: 2007-12-30), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2006-01-01).
Comparison to Sector (Pharmaceuticals, Biotechnology & Life Sciences)
Illumina Inc., total asset turnover, long-term trends, comparison to sector (pharmaceuticals, biotechnology & life sciences)
| Illumina Inc. | Pharmaceuticals, Biotechnology & Life Sciences | |
|---|---|---|
| Dec 31, 2020 | 0.43 | 0.39 |
| Dec 29, 2019 | 0.48 | 0.39 |
| Dec 30, 2018 | 0.48 | 0.45 |
| Dec 31, 2017 | 0.52 | 0.40 |
| Jan 1, 2017 | 0.56 | 0.41 |
| Jan 3, 2016 | 0.60 | 0.42 |
| Dec 28, 2014 | 0.56 | 0.44 |
| Dec 29, 2013 | 0.47 | 0.43 |
| Dec 30, 2012 | 0.45 | 0.45 |
| Jan 1, 2012 | 0.48 | 0.47 |
| Jan 2, 2011 | 0.49 | 0.47 |
| Jan 3, 2010 | 0.47 | 0.39 |
| Dec 28, 2008 | 0.42 | 0.57 |
| Dec 30, 2007 | 0.37 | 0.56 |
| Dec 31, 2006 | 0.61 | 0.54 |
| Jan 1, 2006 | 0.73 | 0.57 |
Based on: 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-29), 10-K (reporting date: 2018-12-30), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2017-01-01), 10-K (reporting date: 2016-01-03), 10-K (reporting date: 2014-12-28), 10-K (reporting date: 2013-12-29), 10-K (reporting date: 2012-12-30), 10-K (reporting date: 2012-01-01), 10-K (reporting date: 2011-01-02), 10-K (reporting date: 2010-01-03), 10-K (reporting date: 2008-12-28), 10-K (reporting date: 2007-12-30), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2006-01-01).
Comparison to Industry (Health Care)
Illumina Inc., total asset turnover, long-term trends, comparison to industry (health care)
| Illumina Inc. | Health Care | |
|---|---|---|
| Dec 31, 2020 | 0.43 | 0.64 |
| Dec 29, 2019 | 0.48 | 0.65 |
| Dec 30, 2018 | 0.48 | 0.68 |
| Dec 31, 2017 | 0.52 | 0.66 |
| Jan 1, 2017 | 0.56 | 0.67 |
| Jan 3, 2016 | 0.60 | 0.64 |
| Dec 28, 2014 | 0.56 | 0.69 |
| Dec 29, 2013 | 0.47 | 0.67 |
| Dec 30, 2012 | 0.45 | 0.67 |
| Jan 1, 2012 | 0.48 | 0.69 |
| Jan 2, 2011 | 0.49 | 0.68 |
| Jan 3, 2010 | 0.47 | 0.63 |
| Dec 28, 2008 | 0.42 | 0.80 |
| Dec 30, 2007 | 0.37 | 0.77 |
| Dec 31, 2006 | 0.61 | 0.74 |
| Jan 1, 2006 | 0.73 | 0.72 |
Based on: 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-29), 10-K (reporting date: 2018-12-30), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2017-01-01), 10-K (reporting date: 2016-01-03), 10-K (reporting date: 2014-12-28), 10-K (reporting date: 2013-12-29), 10-K (reporting date: 2012-12-30), 10-K (reporting date: 2012-01-01), 10-K (reporting date: 2011-01-02), 10-K (reporting date: 2010-01-03), 10-K (reporting date: 2008-12-28), 10-K (reporting date: 2007-12-30), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2006-01-01).